| Product NDC: | 50458-625 |
| Proprietary Name: | Parafon Forte DSC |
| Non Proprietary Name: | chlorzoxazone |
| Active Ingredient(s): | 500 mg/1 & nbsp; chlorzoxazone |
| Administration Route(s): | ORAL |
| Dosage Form(s): | TABLET |
| Coding System: | National Drug Codes(NDC) |
| Product NDC: | 50458-625 |
| Labeler Name: | Janssen Pharmaceuticals, Inc. |
| Product Type: | HUMAN PRESCRIPTION DRUG |
| FDA Application Number: | NDA011529 |
| Marketing Category: | NDA |
| Start Marketing Date: | 19870615 |
| Package NDC: | 50458-625-60 |
| Package Description: | 100 TABLET in 1 BOTTLE (50458-625-60) |
| NDC Code | 50458-625-60 |
| Proprietary Name | Parafon Forte DSC |
| Package Description | 100 TABLET in 1 BOTTLE (50458-625-60) |
| Product NDC | 50458-625 |
| Product Type Name | HUMAN PRESCRIPTION DRUG |
| Non Proprietary Name | chlorzoxazone |
| Dosage Form Name | TABLET |
| Route Name | ORAL |
| Start Marketing Date | 19870615 |
| Marketing Category Name | NDA |
| Labeler Name | Janssen Pharmaceuticals, Inc. |
| Substance Name | CHLORZOXAZONE |
| Strength Number | 500 |
| Strength Unit | mg/1 |
| Pharmaceutical Classes | Centrally-mediated Muscle Relaxation [PE],Muscle Relaxant [EPC] |